ATE437650T1 - Tyrosinasemutante und verfahren zur verwendung davon - Google Patents

Tyrosinasemutante und verfahren zur verwendung davon

Info

Publication number
ATE437650T1
ATE437650T1 AT04794411T AT04794411T ATE437650T1 AT E437650 T1 ATE437650 T1 AT E437650T1 AT 04794411 T AT04794411 T AT 04794411T AT 04794411 T AT04794411 T AT 04794411T AT E437650 T1 ATE437650 T1 AT E437650T1
Authority
AT
Austria
Prior art keywords
tyrosinase
tyrosinase mutant
mutant
elicit
polynucleotides
Prior art date
Application number
AT04794411T
Other languages
English (en)
Inventor
Stefana M Petrescu
Costin I Popescu
Raymond A Dwek
Original Assignee
United Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Therapeutics Corp filed Critical United Therapeutics Corp
Application granted granted Critical
Publication of ATE437650T1 publication Critical patent/ATE437650T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
    • C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
    • C12N9/0059—Catechol oxidase (1.10.3.1), i.e. tyrosinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04794411T 2003-10-07 2004-10-07 Tyrosinasemutante und verfahren zur verwendung davon ATE437650T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50887903P 2003-10-07 2003-10-07
PCT/US2004/033048 WO2005035723A2 (en) 2003-10-07 2004-10-07 Tyrosinase mutant and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE437650T1 true ATE437650T1 (de) 2009-08-15

Family

ID=34434936

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04794411T ATE437650T1 (de) 2003-10-07 2004-10-07 Tyrosinasemutante und verfahren zur verwendung davon

Country Status (10)

Country Link
US (2) US20050142143A1 (de)
EP (1) EP1689430B1 (de)
JP (1) JP4734251B2 (de)
KR (1) KR20060114326A (de)
CN (1) CN1863552B (de)
AT (1) ATE437650T1 (de)
CA (1) CA2541833A1 (de)
DE (1) DE602004022323D1 (de)
ES (1) ES2329904T3 (de)
WO (1) WO2005035723A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016109524A1 (de) 2015-12-30 2017-07-06 Dewertokin Gmbh Schlaf-oder Ruhemöbel und elektromotorischer Möbelantrieb für ein solches Möbel sowie Verfahren zum Bereitstellen eines Informations und/oder Warnsignals durch einen elektromotorischen Möbelantrieb
MA45797A (fr) 2016-08-01 2021-04-21 Hope Medicine Nanjing Co Ltd Mutant de mg53, son procédé de préparation et ses utilisations
WO2018124623A1 (ko) * 2016-12-29 2018-07-05 충남대학교 산학협력단 신규 재조합 티로시나아제

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6472375B1 (en) * 1998-04-16 2002-10-29 John Wayne Cancer Institute DNA vaccine and methods for its use

Also Published As

Publication number Publication date
JP2007507240A (ja) 2007-03-29
WO2005035723A2 (en) 2005-04-21
WO2005035723A3 (en) 2006-01-19
KR20060114326A (ko) 2006-11-06
CN1863552B (zh) 2012-06-27
EP1689430A4 (de) 2007-08-29
CN1863552A (zh) 2006-11-15
US20120034675A1 (en) 2012-02-09
EP1689430B1 (de) 2009-07-29
US20050142143A1 (en) 2005-06-30
CA2541833A1 (en) 2005-04-21
ES2329904T3 (es) 2009-12-02
DE602004022323D1 (de) 2009-09-10
JP4734251B2 (ja) 2011-07-27
EP1689430A2 (de) 2006-08-16

Similar Documents

Publication Publication Date Title
IL226717A (en) Isolated nucleic acids encoded by anti-beta human antibodies 7
ATE471374T1 (de) Immunomodulatorische polynukleotide und verfahren zur deren verwendung
DE60328150D1 (de) System und Methode zur Erzeugung von Anfangs-Vektoren
DK1434791T3 (da) Specifikke bindingsmidler til human angiopoietin-2
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
TW200505942A (en) Antibody molecules having specificity for human IL-1β
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
TW200738270A (en) Method of treating depression using a TNFα antibody
CY1113243T1 (el) Μεθοδοι θεραπειας με χρηση αντισωματων cτlα-4
UA93855C2 (ru) Вакцина, способствует росту, базирующейся ha нейтрализующем эпитопе
ATE369144T1 (de) Verfahren zur steigerung des haarwuchses durch wnt polypeptid
WO2003089457A3 (en) Peptide inhibitors of protein kinase c ϝ for pain management
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
DE60332024D1 (de) Verfahren zur herstellung von soja protein
WO2003103571A3 (en) VACCINES AGAINST FLAVIVIRUSES
NO20055309L (no) Slurp-1 samrnensetninger og fremgangsmater for anvendelse derav
DK1530637T3 (da) Carlsberg-subtilisin-proteiner med nedsat immunogenitet
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE602005021766D1 (de) Verfahren zur behandlung von atherosklerose
ATE513040T1 (de) Zinkfingerdomänenbibliotheken
DE602005012686D1 (de) Zusammensetzungen aus demethylierenden mitteln als verstärker der immuntherapie zur behanldung von cngen und behandlungsverfahren dafür
IL149416A0 (en) Human enzymes of the metalloprotease family
ATE437650T1 (de) Tyrosinasemutante und verfahren zur verwendung davon
WO2004039334A3 (en) CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING
DK1385993T3 (da) Fremgangsmåde til detektering og behandling af tuberøs sclerose kompleksrelaterede lidelser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties